Prevalence of hypertension in member countries of South Asian Association for Regional Cooperation (SAARC): Systematic review and meta-analysis

Medicine (United States)

Volumn 93, Issue 13, 2014, Pages

  Neupane, Dinesh ^a   McLachlan, Craig S ^b   Sharma, Rajan ^c   Gyawali, Bishal ^c   Khanal, Vishnu ^d   Mishra, Shiva Raj ^e   Christensen, Bo ^f   Kallestrup, Per ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d CURTIN UNIVERSITY   (Australia)

^e Nepal Development Society ^*  (Nepal)

^f AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHOLESTEROL; TRIACYLGLYCEROL;

ALCOHOL CONSUMPTION; ARTICLE; BANGLADESH; BHUTAN; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FAMILY HISTORY; FAT INTAKE; FOOD INTAKE; FRUIT; HEALTH CARE PERSONNEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INDIA; MALDIVES; NEPAL; OBESITY; OBSERVATIONAL STUDY; PAKISTAN; PREHYPERTENSION; PREVALENCE; PRIORITY JOURNAL; RURAL AREA; SALT INTAKE; SEX RATIO; SOUTH ASIAN; SRI LANKA; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; URBAN AREA; ASIA; ASIAN; BLOOD PRESSURE; FEMALE; MALE; META ANALYSIS; REVIEW; RISK FACTOR;

ASIA; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; MALE; PREVALENCE; RISK FACTORS;

EID: 84928238582     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000074     Document Type: Article

References (61)

1. Alwan A, Armstrong T, Bettcher D, et al. Global Status Report on Noncommunicable Diseases. Geneva, Switzerland: World Health Organisation; 2011.
2. WHO. A Global Brief on Hypertension. Geneva, Switzerland: World Health Organisation; 2013.
3. Olives C, Myerson R, Morkdad AH, et al. Prevalence, awareness, treatment, and control of hypertension in United States countries, 2001-2009. PLoS One. 2013;8:e60308.
4. Krishnan A, Garg R, Kahandaliyanage A. Hypertension in the South-East Asia region: an overview. Reg Health Forum. 2013;17:7-14.
5. WHO. Blood Pressure: Raised Blood Pressure by WHO Region. 2013. http://apps.who.int/gho/data/view.main.2550?lang = en. Accessed March 10, 2014.
6. WHO. Blood Pressure: Raised Blood Pressure by Country. 2013. http://apps.who.int/gho/data/view.main.2465?lang. Accessed March 10, 2014.
7. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-Analysis of Observational Studies in Epidemiology (MOOSE) Group. J Am Med Assoc. 2000;283:2008-2012.
8. Vergnes JN, Marchal-Sixou C, Nabet C, et al. Ethics in systematic reviews. J Med Ethics. 2010;36:771-774.
9. Chalmers J, MacMahon S, Mancia G, et al. World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines Sub-Committee of the World Health Organization. Clin Exp Hypertens. 1999;21:1009-1060.
10. Thawornchaisit P, De Looze F, Reid CM, et al. Thai cohort study team. Validity of self-reported hypertension: findings from the Thai cohort study compared to physician telephone interview. Glob J Health Sci. 2013;6:1-11.
11. WHO. Blood Pressure: Raised Blood Pressure by WHO Region. Geneva, Switzerland: World Health Organisation; 2013.
12. von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344-349.
13. Chen Y, Factor-Litvak P, Howe GR, et al. Nutritional influence on risk of high blood pressure in Bangladesh: a population-based crosssectional study. Am J Clin Nutr. 2006;84:1224-1232.
14. Gupta PC, Gupta R, Pednekar MS. Hypertension prevalence and blood pressure trends in 88653 subjects in Mumbai, India. J Hum Hypertens. 2004;18:907-910.
15. Razzaque A, Nahar L, Haider A, et al. Sociodemographic differentials of selected noncommunicable diseases risk factors among adults in Matlab Bangladesh: findings from a WHO STEPS survey. Asia Pac J Public Health. 2011;23:183-191.
16. Sharma SK, Ghimire A, Radhakrishnan J, et al. Prevalence of hypertension, obesity, diabetes, and metabolic syndrome in Nepal. Int J Hypertens. 2011;11:821971.
17. Bharucha NE, Kuruvilla T. Hypertension in the Parsi community of Bombay: a study on prevalence, awareness and compliance to treatment. BMC Public Health. 2003;3:1.
18. Aboobakur M, Latheef A, Mohamed AJ, et al. Surveillance for noncommunicable disease risk factors in Maldives: results from the first STEPS survey in Male. Int J Public Health. 2010;55:489-496.
19. Gupta R, Gupta VP, Sharma M, et al. Prevalence of coronary heart disease and risk factors in an urban Indian population. Indian Heart J. 2002;54:59-66.
20. Malavige GN, Alwis NMd, Weerasooriya N, et al. Increasing diabetes and vascular risk factors in a sub-urban Sri Lankan population. Diabetes Res Clin Pract. 2002;57:143-145.
21. Shah SM, Luby S, Rahbar M, et al. Hypertension and its determinants among adults in high mountain villages of the Northern Northen Areas of Pakistan. J Hum Hypertens. 2001;15:107-112.
22. Wijewardene K, Mohideer MR, Mendis S, et al. Prevalence of hypertension, diabetes and obesity: baseline findings of a population based survey in four provinces in Sri Lanka. Ceylon Med J. 2005;50:62-70.
23. Bhardwaj R, Kandoria A, Marwah R, et al. Prevalence, awareness and control of hypertension in rural communities of Himachal Pradesh. J Assoc Phys India. 2010;58:423-425.
24. Biswas M, Manna CK. Prevalence of hypertension and sociodemographic factors within the scheduled caste community of the district Nadia, West Bengal, India. High Blood Press Cardiovasc Prev. 2011;8:179-185.
25. Gupta R, Deedwania PC, Achari V, et al. Normotension, prehypertension, and hypertension in urban middle-class subjects in India: prevalence, awareness, treatment, and control. Am J Hypertens. 2013;26:83-94.
26. Kumar S, Mishra CP. Prevalence and spectrum of hypertension in a rural area. Kathmandu Univ Med J. 2008;6:181-183.
27. Mehta KD, Karki P, Lamsal M, et al. Hyperglycemia, glucose intolerance, hypertension and socioeconomic position in eastern Nepal. Southeast Asian J Trop Med Public Health. 2011;42: 197-207.
28. Mohan V, Deepa M, Farooq S, et al. Prevalence, awareness and control of hypertension in Chennai: the Chennai urban rural epidemiology study (CURES-52). J Assoc Phys India. 2007;55:326-332.
29. Singh RB, Fedacko J, Pella D, et al. Prevalence and risk fators for prehypertension and hypertension in five Indian cities. Acta Cardiol. 2011;66:29-37.
30. Yadav S, Boddula R, Genitta G, et al. Prevalence & risk factors of pre-hypertension & hypertension in an affluent north Indian Population. Indian J Med Res. 2008;128:712-720.
31. Jafar TH, Levey AS, Jafary FH, et al. Ethnic subgroup differences in hypertension in Pakistan. J Hypertens. 2003;21:905-912.
32. Ministry of Health and Population, Government of Nepal, Society for Local Integrated Development Nepal, WHO. WHO STEPS surveillance: non-communicable disease risk factors survey. Kathmandu. 2008.
33. Jonas JB, Nangia V, Matin A, et al. Prevalence, awareness, control and associations of arterial hypertension in a rural central India population: the Central India Eye and Medical Study. Am J Hypertens. 2010;23:347-350.
34. Vaidya A, Pathak RP, Pandey MRJ. Prevalence of hypertension in Nepalese community triples in 25 years: a repeat cross-sectional study in rural Kathmandu. Indian Heart. 2012;64:128-131.
35. Kaur P, Rao SR, Gupte MD. Prevalence, awareness, treatment, control and risk factors for hypertension in a rural population in South India. Int J Public Health. 2012;57:87-94.
36. Meshram II, Arlappa N, Balkrishna N, et al. Prevalence of hypertension, its correlates and awareness among adult tribal population of Kerala state, India. J Postgrad Med. 2012;58:255-261.
37. Shanthirani CS, Pradeepa R, Deepa R, et al. Prevalence and risk factors of hypertension in a selected South India population: the Chennai Urban Population Study. J Assoc Phys India. 2002;51:20-27.
38. Ministry of Health and Family Welfare, WHO, Bangladesh Society of Medicine. Non-communicable disease risk factor survey Bangladesh 2010. Dhaka. 2010.
39. Ministry of Health, Royal Government of Bhutan. Report on 2007 STEPS survey for risk factors and prevalence of noncommunicable diseases in Thimphu. Thimphu. 2009.
40. Ministry of Healthcare and Nutrition, Sri Lanka Government. National non-communicable disease risk factor survey. Colombo. 2008.
41. Anand K, Shah B, Gupta V, et al. Risk factors for noncommunicable disease in urban Haryana: a study using the STEPS approach. Indian Heart J. 2008;60:9-18.
42. Ahlawat SK, Singh MM, Kumar R, et al. Time trends in the prevalence of hypertension and associated risk factors in Chandigarh. J Indian Med Assoc. 2002;100:547-552.
43. Chaturvedi S, Pant M, Neelam, et al. Hypertension in Delhi: prevalence, awareness, treatment and control. Trop Doct. 2007;37:142-145.
44. Kusuma YS, Babu BV, Naidu IM. Prevalence of hypertension in some cross-cultural populations of Visakhapatnam district, South India. Ethn Dis. 2004;14:250-259.
45. Shrestha UK, Singh DL, Bhattarai MD. The prevalence of hypertension and diabetes defined by fasting and 2-h plasma glucose criteria in urban Nepal. Diabet Med. 2006;23:1130-1135.
46. Tailakh A, Evangelista LS, Mentes JC, et al. Hypertension prevalence, awareness, and control in Arab countries: a systematic review. Nurs Health Sci. 2014;16:126-130.
47. Kearney PM, Whelton M, Reynolds K, et al. Worldwide prevalence of hypertension: a systematic review. J Hypertens. 2004;22:11-19.
48. Wolf-Marier K, Cooper RS, Banegas JR. Hypertension prevalence and blood pressure levels in 6 European countries, Canada and the United States. J Am Med Assoc. 2003;289:2363-2369.
49. Addo J, Smeeth L, Leon DA. Hypertension in Sub-Saharan Africa. Hypertension. 2007;50:1012-1018.
50. Beaglehole R, Bonita R, Horton R, et al. Priority actions for the non-communicable disease crisis. Lancet. 2011;377:1438-1447.
51. Mendis S. Hypertension: a silent contributor to the global cardiovascular epidemic. Reg Health Forum. 2013;17:1-6.
52. Jayawarden R, Byrne NM, Soares MJ, et al. Prevalence, trends and associated socio-economic factors of obesity in South Asia. Obes Facts. 2012;6:404-414.
53. Ibrahim MM, Damasceno A. Hypertension in developing countries. Lancet. 2012;380:611-619.
54. Colhoun HM, Hemingway H, Poulter NR. Socio-economic status and blood pressure: an overview analysis. J Hum Hypertens. 1998;12:91-110.
55. Zhao D, Qi Y, Zheng Z, et al. Dietary factors associated with hypertension. Nat Rev Cardiol. 2011;8:456-465.
56. Minor DS, Wofford MR, Jones DW. Racial and ethnic differences in hypertension. Curr Atheroscler Rep. 2008;10:121-127.
57. Gluckman PD, Hanson MA, Buklijas T, et al. Epigenetic mechanisms that underpin metabolic and cardiovascular diseases. Nat Rev Endocrinol. 2009;5:401-408.
58. Gupta R. Trends in hypertension epidemiology in India. J Hum Hypertens. 2004;18:73-78.
59. Whelton PK, Appel LJ, Cutler JA, et al. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. J Am Med Assoc. 2002;288:1882-1888.
60. Thom TJ. International mortality from heart disease: rates and trends. Int J Epidemiol. 1989;18:s20-s28.
61. Morrison A, Polisena J, Hosereau D, et al. The effect of Englishlanguage restriction on systematic review-based meta-analyses: a systematic review of empirical studies. Int J Technol Assess Health Care. 2012;28:138-144.